KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Community Health Systems (CYH) EBITDA (2016 - 2025)

Community Health Systems has reported EBITDA over the past 16 years, most recently at $450.0 million for Q4 2025.

  • Quarterly EBITDA rose 238.89% to $450.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $881.0 million through Dec 2025, up 386.04% year-over-year, with the annual reading at $1.5 billion for FY2025, 2580.0% up from the prior year.
  • EBITDA was $450.0 million for Q4 2025 at Community Health Systems, up from $243.0 million in the prior quarter.
  • Over five years, EBITDA peaked at $512.0 million in Q2 2025 and troughed at -$519.0 million in Q4 2022.
  • The 5-year median for EBITDA is $238.0 million (2024), against an average of $141.8 million.
  • Biggest five-year swings in EBITDA: crashed 222.41% in 2022 and later surged 238.89% in 2025.
  • Tracing CYH's EBITDA over 5 years: stood at $424.0 million in 2021, then crashed by 222.41% to -$519.0 million in 2022, then skyrocketed by 96.72% to -$17.0 million in 2023, then tumbled by 1805.88% to -$324.0 million in 2024, then surged by 238.89% to $450.0 million in 2025.
  • According to Business Quant data, EBITDA over the past three periods came in at $450.0 million, $243.0 million, and $512.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.